OnePass Medical

Company Overview

Snapshot

Founded in July 2018 by Jacob BenArie and Jesse Yishai Lachter, OnePass Medical operates with 1-10 employees. The company has secured $3.47M in total capital across three funding rounds and holds a patent for its single-use needle for endoscopic ultrasound-guided biopsy. In April 2021, OnePass Medical secured a grant from the Israel Innovation Authority.

Business overview

OnePass Medical develops a disposable platform for interventional endoscopy and bronchoscopy treatments, focusing on enhancing diagnostic accuracy and reducing procedure time. Its core product, InstaFAN, is a biopsy device designed to collect multiple tissue samples from different areas of a tumor in a single procedure. The platform is particularly effective for endoscopy-ultrasound guided biopsies and bronchoscopies, with potential for expansion into therapeutic applications like multipronged drug delivery and ablation. The company operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices, Diagnostics Devices, and Medical Treatment & Therapeutics categories globally.

Company Intelligence Q&A

What is OnePass Medical's primary product?

OnePass Medical's primary product is InstaFAN, a biopsy device designed for collecting multiple tissue samples from different areas of a tumor in a single procedure, enhancing diagnostic accuracy and reducing time and repeat biopsies.

When was OnePass Medical founded?

OnePass Medical was founded in July 2018 by Jacob BenArie and Jesse Yishai Lachter.

What is the total capital raised by OnePass Medical?

OnePass Medical has raised a total of $3.47M across three funding rounds.

Has OnePass Medical received any grants?

In April 2021, OnePass Medical secured a grant from the Israel Innovation Authority.

What is the strategic focus of OnePass Medical's collaborations?

OnePass Medical has two ongoing strategic development collaborations with Mayo Clinic, both including licensing agreements. One collaboration focuses on gastro-intestinal applications of the InstaFAN platform, where OnePass Medical has demonstrated significant clinical efficacy through first-in-man experiences.